Indication
Insulin Receptor Mutation
1 clinical trial
1 product
Clinical trial
Phase II Study of Growth Hormone Inhibition Using Pegvisomant In Severe Insulin ResistanceStatus: Recruiting, Estimated PCD: 2025-01-30
Product
Pegvisomant1 clinical trial
1 product